Based on the results identified in this study, we suggest that JPH3 is a dosage-sensitive (haploinsufficient) disease gene and some allelic and phenotypic heterogeneity may occur in JPH3-related neurological disorders. This evidence concerns the gene JPH3 and nervous system disorder.